Edmonton, Canada

Jatinder Kaur

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Purdue Research Foundation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jatinder Kaur. Retrieved from https://idiyas.com/inventor/jatinder-kaur-g5wd37g9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jatinder Kaur: Innovator in Antibiotic Development

Introduction

Jatinder Kaur is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic compounds. His work focuses on addressing the growing challenge of multidrug-resistant bacteria.

Latest Patents

Jatinder Kaur holds a patent for "Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria." This invention relates to innovative compounds that serve as narrow-spectrum antibiotics targeting drug-resistant bacteria. The methods described in his patent provide new avenues for treating infectious diseases in mammals using these carbonic anhydrase inhibitors or pharmaceutical formulations derived from them.

Career Highlights

Kaur is affiliated with the Purdue Research Foundation, where he continues to advance his research and development efforts. His work is crucial in the ongoing battle against antibiotic resistance, a pressing global health issue.

Collaborations

Some of his notable coworkers include Daniel Patrick Flaherty and Mohamed Seleem, who contribute to the collaborative efforts in research and innovation within the foundation.

Conclusion

Jatinder Kaur's innovative work in antibiotic development highlights the importance of addressing drug resistance in bacteria. His contributions are vital for the future of therapeutic treatments in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…